Nortran Pharmaceutical -NRT.V Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Nortran Pharmaceutical -NRT.V

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: trustmanic who wrote (89)	2/28/1997 7:06:00 AM
From: Chuca Marsh	of 1185

Yesterday I posted on CYTO thread about Nortran, about the Provost Report as next month Provost is featuring Cytogen, a great little biotech which has great in development and phase completed that will hit the news wires at any time; just like Nortran, Great Company to Keep. Nice that both are "written -up by such a high caliber research analyst firm" is all that I can say, so when both are put in the same standard of analyst reporting we must respect the science of BOTH! Validation can come from such sources and within a week you will be reading about a new drug-thearphy approval by the FDA on the latter. ChucsawyesterdaythatFDAadvisorypanelmadeacommentofHOLDOFF on a competing companies' drug for "congestive heart failure"-maybe we have the one that will easily come to FRUITION-AT-NORTRAN! AnotherNEWCLASSOFDRUGBIOTECHFORTHEHEART=NRT=TOC SDS/CHF/HA-with THE widow for delivery. by Chuc Marshall, Adhoc Acting CEO Nortran Pharmaceuticals Flash News Release will confirm (or deny)the above two lines(by-line).

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next